ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Nanozyme Aptasensor Array for Predictive Sensing of Virulent and Antibiotic-Resistant Staphylococcus Aureus strains.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Staphylococcus aureus, an important human pathogen, is the leading cause of infection-related death globally. It stands out as the only bacterial pathogen, apart from Mycobacterium tuberculosis, responsible for over a million fatalities each year. The emergence of antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA), has created challenges in detecting S. aureus infections, as treatment depends on identifying the specific strain causing the infection. This study highlights the use of an array-based colorimetric aptasensor platform using aptamers, which exhibit specific binding across different S. aureus strains. This platform generates unique colorimetric fingerprints for different S. aureus strains, thus enabling an unbiased and strain-specific detection system. The unique signatures arise from differences in the dissociation dynamics of aptamers on the surface of nanozymes. The sensor response was analysed using pattern recognition tools trained on responses from the aptasensor array to identify individual S. aureus strains. Furthermore, the sensing platform offers additional functionality by providing information about the virulence factors associated with pathogenicity, such as the presence of markers like Panton-Valentine leukocidin (pvl), which is a marker of increased virulence and sensitivity/resistance to antibiotics. The platform would be capable of recognising previously unencountered S. aureus strains, enabling predictive capabilities and utility in clinical diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.